The Clorox Company (NYSE:CLX) offers investors a high dividend yield, but investors should weigh that income against deteriorating profitability and the costs of restoring growth. The company’s FY2026 earnings indicated that net sales decreased by 5% to $6.72 billion and that diluted earnings per share dropped by 26% to $4.81. Gross margin fell by 290 basis points to 42.3%, a result of weaker sales, higher manufacturing and logistics costs, and the expenses linked to the acquisition of GOJO Industries.
Additionally, operating cash flow decreased by 38% to $612 million. The company continues to benefit from well-known brands including Clorox, Glad, Hidden Valley, and Purell, as this helps to maintain steady demand. The problem, however, is in turning that brand strength into profitable organic growth rather than depending on acquisitions and the easier year-on-year comparisons. For investors seeking income opportunities beyond established consumer brands, our Best 52-Week Low Dividend Stocks list offers a closer look at dividend-paying stocks that have fallen sharply in price, potentially opening the door to attractive entry points.
The management has set an expected organic sales growth for fiscal 2027 of between 3.5% and 4.5%, but expects adjusted EPS growth to be only between 3% and 8%. Since the projected gross margin will be about 42%, it indicates that cost pressures will still be limiting the recovery of earnings.
Is Clorox Cheap Enough to Reward Investors?
The Clorox Company is trading at a forward P/E of 14.95 and a trailing P/E of 18.12 at $86.20; the forward P/E has fallen from 19.80 in September 2025 and from 16.72 in December 2025, which shows a considerable valuation reset. The forward multiple of 14.95 corresponds to an earnings yield of about 6.7%. This amount is only roughly 1.6 percentage points higher than the 10-year Treasury yield of 5.09% on October 16. This kind of gap represents only modest compensation for the volatility of equity prices, the risk associated with execution, and the chance that earnings will fail to meet expectations. Though CLX is trading at a lower multiple, other beaten-down dividend stocks may offer more compelling entry points. Our 52-Week Low Dividend Stocks list highlights opportunities worth exploring, including the #6 stock on our list, which trades at a forward P/E of just 11x.
Clorox is also trading at a price below Procter & Gamble’s forward P/E of about 20.5, and this discount is justified considering the company’s weaker recent performance; furthermore, its historical forward multiple of 19.80 a year earlier also indicates that the market had already lowered its expectations. The main issue is whether the discount properly takes into account the recovery that is expected. The management guidance for GAAP EPS of $5.41 to $5.71 suggests a growth of about 13% at the midpoint on the back of $4.81 in fiscal 2026. Read P&G’s complete valuation analysis here.
However, adjusted EPS growth is expected to amount to only 3% to 8%. This gap shows just how much the recovery relies on acquisition costs, inventory comparisons, and other adjustments. The valuation can be considered defensible if margins level out, but recovering premium multiples will require stronger underlying growth.
Also read: Clorox Has Some Great Brands. Is its Stock a Good Value?
Can Clorox Sustain Its Nearly 6% Dividend Yield?
Clorox grew its quarterly dividend to $1.25, which amounts to $5 per year. With the share price at $86.20, the yield works out at 5.8%, a figure that is considerably higher than the five-year average yield of 3.46%. The company’s trailing payout ratio is 103.12%, indicating that the dividend has exceeded the company’s most recent GAAP earnings. If the fiscal 2027 GAAP EPS guidance is used, the annual dividend would take up about 88% to 92% of the earnings. While this is more feasible, it still leaves only limited room for any setbacks. That said, with the latest increase, CLX is getting closer to becoming a Dividend King. Find which companies have unlocked this achievement.
Moreover, the drop in operating cash flow to $612 million in fiscal 2026 should prompt caution, since dividends must ultimately be financed by cash generation, not merely accounting earnings. The dividend could contribute significantly to total returns if earnings rebound and valuation stabilizes. However, high commodity costs, consumers who are sensitive to price changes, the challenges of integrating acquisitions, and ongoing margin pressure could all limit future dividends. In the meantime, the 10-year Treasury provides a yield of 5.09% without involving oneself in business risk.
Conclusion
Clorox’s dividend is attractive, and its forward valuation is more sensible than its historical premium indicates. However, the stock is not an obvious income deal since the earnings yield provides only a small advantage over Treasury securities and the dividend leaves very little room for disappointment. Therefore, investors should seek to find evidence of sustainable organic growth and improved cash generation before considering the current yield as a compelling risk-adjusted opportunity.
READ NEXT: Pentair’s Dividend Looks Sustainable. What Could Go Wrong? and This Stock Has a Tempting 7% Dividend Yield, but Is It Sustainable?
This article is originally published at Insider Monkey.
